SYK · 10-Q · 2026Q2 · Full report

Revenue Performance and Mix

STRYKER CORP · 2026-07-31 · Importance 49 · Surprise 32 · From source text

Second-quarter 2026 net sales increased 9.4% year over year to $6,589 million, including 9.0% constant-currency growth driven by higher unit volume and a 0.4% foreign-exchange benefit. Six-month net sales increased 6.1% to $12,609 million, or 5.0% in constant currency, with 5.6% constant-currency organic growth excluding a 0.8% acquisition and divestiture impact. MedSurg and Neurotechnology sales rose 9.7% in the quarter and 7.4% year to date, while Orthopaedics sales rose 9.1% and 4.5%, respectively. International sales grew 11.0% in the quarter and 9.7% year to date, exceeding U.S. growth of 8.9% and 4.9%, while spinal implant sales declined 96.9% year to date following the business sale.

Key facts

• Spinal Implants sales declined materially: three months international -36.7% and total -36.7%; six months total decline (96.9)% (and close to -97.1% in constant currency). source
• Three months 2026 net sales: $6,589 million, up 9.4% as reported and up 9.0% in constant currency. source
• MedSurg and Neurotechnology three months 2026 net sales: United States $2,854 million (up 8.7%); International $1,003 million (total MedSurg and Neurotechnology $3,625 million, up 9.7%). source
• Orthopaedics three months 2026 net sales: United States $2,105 million (up 9.1%); International $859 million implied (total Orthopaedics $2,964 million, up 9.1%). source
• Six months 2026 net sales: $12,609 million, up 6.1% as reported and up 5.0% in constant currency. source
• Excluding impact of acquisitions and divestitures, three months 2026 sales grew 9.0% in constant currency; excluding (0.8)% impact of acquisitions and divestitures, six months constant currency net sales increased by 5.6% (5.8% earlier stated as overall excluding acquisitions/divestitures). source

Impact estimates